Early results of transurethral vaporisation of prostate in Nigeria.
OBJECTIVE
to determine the effectiveness of transurethral electrovaporisation of prostate for the relief of obstructive prostatic disease in Nigeria.


METHODS
Consecutive patients presenting with obstructive prostatic disease with prostate size of less than 40gm were treated by transurethral electrovaporisation of prostate using a 5mm rollerball electrode.


RESULTS
A total of 27 patients were entered into the study, 7(26%) had clinically malignant prostates; 2 patients (7%) had immediate post operative retention requiring resection of residual prostate. No patients exhibited the clinical features of TUR syndrome, all patients were discharged by the 4th post operative day and required no blood transfusions.


CONCLUSIONS
Transurethral electrovaporisation is effective for treatment of obstructive prostatic disease, benign or malignant. using the 5mm rollerball instead of the recommended vaportrode still confers benefit over TURP. TEVP confers all the benefits of TURP with less mobidity.
Akporiaye
Leslie E
LE
Baptist Medical Centre, Eku, Sapele, Delta State, Nigeria.
D000208:Acute Disease; D000368:Aged; D016063:Blood Loss, Surgical; D004598:Electrosurgery / Q000009:adverse effects / Q000295:instrumentation / Q000379:methods*; D005998:Glycine / Q000627:therapeutic use; D006801:Humans; D007902:Length of Stay / Q000706:statistics & numerical data; D008297:Male; D008875:Middle Aged; D019060:Minimally Invasive Surgical Procedures / Q000009:adverse effects / Q000295:instrumentation / Q000379:methods*; D009017:Morbidity; D018579:Patient Selection; D011470:Prostatic Hyperplasia / Q000150:complications / Q000175:diagnosis / Q000601:surgery*; D011471:Prostatic Neoplasms / Q000150:complications / Q000175:diagnosis / Q000601:surgery*; D012189:Retrospective Studies; D012449:Safety; D007507:Therapeutic Irrigation / Q000379:methods; D020728:Transurethral Resection of Prostate / Q000009:adverse effects / Q000295:instrumentation / Q000379:methods*; D016896:Treatment Outcome; D016055:Urinary Retention / Q000209:etiology
D005998:Glycine